Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel dosage formulation

a technology of dosage formulation and dosage, applied in the field of new dosage formulation, can solve the problems of practical insolubility and achieve the effect of sufficient availability of active compounds

Inactive Publication Date: 2007-03-29
AHMED HASHIM A +2
View PDF12 Cites 35 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The patent text describes a new way to make medication that can be taken by mouth. The method involves melting down the active ingredient and a special polymer, and then mixing them together. This makes the medication easier to absorb in the body. The text also describes a process for making a tablet version of the medication, which can be coated with a special coating to control how it releases in the body. Overall, this method helps to make medication that works better and can be taken more easily."

Problems solved by technology

Such formulations may overcome the disadvantage of practical insolublility in simulated intestinal fluid for these compounds.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel dosage formulation
  • Novel dosage formulation
  • Novel dosage formulation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The following definitions of general terms used herein apply irrespective of whether the terms in question appear alone or in combination. It must be noted that, as used in the specification and the appended claims, the singular forms “a”, “an,” and “the” include plural forms unless the context clearly dictates otherwise.

[0025] The term “lower alkyl” denotes a straight- or branched-chain alkyl group containing from 1 to 7 carbon atoms. Nonlimiting examples of lower alkyl include methyl, ethyl, propyl, isopropyl, n-butyl, i-butyl, t-butyl, and the like.

[0026] The term “alkylene group” means a lower alkyl linker which is bound to a group at either end. Nonlimiting examples of alkylene groups include methylene, ethylene, propylene, and the like.

[0027] The term “lower alkoxy” denotes a alkyl group as defined above, which is attached through an oxygen atom. Nonlimiting examples of lower alkoxy groups include methoxy, ethoxy, propoxy, and the like.

[0028] The term “cycloalkyl” d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
inlet temperatureaaaaaaaaaa
water solubleaaaaaaaaaa
Login to View More

Abstract

The invention relates to a process for preparing a pharmaceutical tablet composition which comprises an active pharmaceutical ingredient of formula I wherein the definitions are described in claim 1, or pharmaceutically acceptable acid addition salts thereof and a water soluble poloxamer in which the compound of formula I and the water soluble poloxamer are processed by hot melt extrusion, and then the hot melt extrudate is mixed with other ingredients to form a tablet, that is optionally coated with a composition comprising an immediate release film coating system and purified water. The invention also relates to such pharmaceutical compositions and hot melt extrudates.

Description

PRIORITY TO RELATED APPLICATIONS [0001] This application claims the benefit of U.S. Provisional Application No. 60 / 719,793, filed Sep. 23, 2005, which is hereby incorporated by reference in its entirety.BACKGROUND OF THE INVENTION [0002] Many substances obtained from modem drug discovery are problematic because of insufficient bioavailability. Such molecules often exhibit very low aqueous solubility and limited solubility in oils. Furthermore many substances exhibit significant food effects, i.e., when drugs and certain foods are taken at the same time they can interact in ways that diminish the effectiveness of the ingested drug or reduce the absorption of food nutrients. Additionally, vitamin and herbal supplements taken with prescribed medication can result in adverse reactions. [0003] Some examples of how foods and drugs can interact include: [0004] Food can speed up or slow down the action of a medication. [0005] Impaired absorption of vitamins and minerals in the body. [0006] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/445A61K9/20
CPCA61K9/1641A61K9/1694A61K9/2031A61K9/2077C07D413/04A61K31/44A61K31/4427A61K31/445A61K31/455A61K9/2095A61P1/08A61P25/22A61P25/24A61P43/00A61K9/20
Inventor AHMED, HASHIM A.PAGE, SUSANNESHAH, NAVNIT HARGOVINDAS
Owner AHMED HASHIM A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com